Krystal Biotech KRYS

$ 163.39 1.59%

Quarterly report 2024-Q3
added 11-04-2024

Krystal Biotech Income Statement 2011-2024 | KRYS

Annual Income Statement Krystal Biotech

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	4.29 B	2 B	1.41 B	1.48 B	840 M	256 M	53.8 M	-	-	-	-	-	-
Shares	27.2 M	25.5 M	22.2 M	18.8 M	15.9 M	11.2 M	5.36 M	-	-	-	-	-	-
Historical Prices	158	78.3	63.5	78.9	53.5	22.4	10.1	-	-	-	-	-	-
Net Income	10.9 M	-140 M	-69.6 M	-32.2 M	-19.1 M	-10.9 M	-7.92 M	-1.15 M	-	-	-	-	-
Revenue	50.7 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-110 M	-145 M	-68.3 M	-33 M	-22.1 M	-11.9 M	-4.77 M	-1.14 M	-	-	-	-	-
Interest Expense	-	-	1.49 M	-	-	-	-	-	-	-	-	-	-
EBITDA	-105 M	-143 M	-66.4 M	-31.1 M	-21.3 M	-11.8 M	-4.75 M	-1.14 M	-	-	-	-	-
Operating Expenses	160 M	145 M	68.3 M	33 M	22.1 M	11.9 M	4.77 M	-	-	-	-	-	-
General and Administrative Expenses	98.4 M	77.7 M	40.4 M	15.1 M	6.46 M	4.16 M	1.56 M	402 K	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Krystal Biotech

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	28.7 M	28.6 M	28.3 M	28.2 M	28 M	26.7 M	25.7 M	25.8 M	25.6 M	25.5 M	25.1 M	25.2 M	22.2 M	22.2 M	21.3 M	19.7 M	19.7 M	18.4 M	17.4 M	17.4 M	17.3 M	14.5 M	14.4 M	14.4 M	10.6 M	10.3 M	10.3 M	10.3 M	4.18 M	3.49 M	3.49 M	-	38 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	27.2 M	15.6 M	932 K	-	80.7 M	-33.2 M	-45.3 M	-	-29.8 M	-28.1 M	-50 M	-	-15.6 M	-16.4 M	-15.8 M	-	-9.61 M	-6.83 M	-5.34 M	-	-4.27 M	-5.35 M	-4.11 M	-	-2.76 M	-2.28 M	-2.15 M	-	-5.27 M	-759 K	-494 K	-	-322 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	83.8 M	70.3 M	45.2 M	-	8.56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	22.4 M	8.57 M	-6.68 M	-	-26 M	-38 M	-48.8 M	-	-31.5 M	-28.8 M	-50.2 M	-	-15.7 M	-16.4 M	-14.4 M	-	-9.68 M	-6.95 M	-5.95 M	-	-5.34 M	-5.89 M	-4.69 M	-	-2.97 M	-2.45 M	-2.28 M	-	-2.09 M	-715 K	-465 K	-	-322 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.49 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	23.7 M	10.4 M	-5.26 M	-	-24.8 M	-36.8 M	-47.7 M	-	-30.8 M	-28.3 M	-49.2 M	-	-13.7 M	-15.2 M	-13.8 M	-	-8.32 M	-6.07 M	-5.53 M	-	-4.59 M	-5.44 M	-4.56 M	-	-2.93 M	-2.43 M	-2.26 M	-	-2.09 M	-712 K	-464 K	-	-322 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	61.4 M	61.7 M	51.9 M	-	34.5 M	38 M	48.8 M	-	31.5 M	28.8 M	50.2 M	-	15.7 M	16.4 M	14.4 M	-	9.68 M	6.95 M	5.95 M	-	5.34 M	5.89 M	4.69 M	-	2.97 M	2.45 M	2.28 M	-	2.09 M	715 K	465 K	-	322 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	28.7 M	27.6 M	26.1 M	-	23.7 M	25.9 M	24 M	-	19.9 M	17.9 M	15.9 M	-	9.57 M	9.8 M	8.15 M	-	4.58 M	3.32 M	2.42 M	-	1.46 M	1.67 M	1.53 M	-	1.06 M	924 K	757 K	-	738 K	269 K	146 K	-	81 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency